Real-time enrollment status for this atherosclerosis clinical trial
Current Status
Recruiting
Checked: August 4, 2026 at 6:56 PM UTC
| NCT Number | NCT07521007 |
| Recruiting Status | Recruiting |
| Condition | Atherosclerosis |
| Phase | PHASE2 |
| Target Enrollment | 456 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Beijing Inno Medicine Co., Ltd. |
| Last Updated on CT.gov | August 4, 2026 (18 hours ago) |
As of August 4, 2026: Clinical trial NCT07521007 is currently recruiting participants. This phase2 study for atherosclerosis is actively seeking new participants at 12 locations across the United States. The study is sponsored by Beijing Inno Medicine Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07521007 is actively recruiting participants as of August 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07521007 was last updated 18 hours ago (August 4, 2026). HelloStudys verifies this status automatically.